Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 198

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients

Satoh-Asahara, Noriko, Sasaki, Yousuke, Wada, Hiromichi, Tochiya, Mayu, Iguchi, Azusa, Nakagawachi, Reiko, Odori, Shinji, Kono, Shigeo, Hasegawa, Koji, Shimatsu, Akira · 2013 · Metabolism

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.metabol.2012.09.004

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 15

  1. Shah, 2011, Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis, Circulation, 124, 2338, 10.1161/CIRCULATIONAHA.111.041418 · DOI · Paper page
  2. Matsubara, 2012, A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice, J Am Coll Cardiol, 59, 265, 10.1016/j.jacc.2011.07.053 · DOI · Paper page
  3. Terasaki, 2012, Effects of PKF275-055, a dipeptidyl peptidase-4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E-null mice, Metabolism, 61, 974, 10.1016/j.metabol.2011.11.011 · DOI
  4. Satoh, 2010, Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone, Diabetes Care, 33, e7, 10.2337/dc09-1315 · DOI
  5. Satoh, 2009, Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome, Hypertens Res, 32, 1004, 10.1038/hr.2009.145 · DOI
  6. Kashiwagi, 2012, International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values, J Diabetes Invest, 3, 39, 10.1111/j.2040-1124.2012.00207.x · DOI · Paper page
  7. Yabe, 2010, Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: comparison of type 2 diabetes patients and healthy controls, J Diabetes Invest, 1, 56, 10.1111/j.2040-1124.2010.00010.x · DOI
  8. Makdissi, 2012, Sitagliptin exerts an anti-inflammatory action, J Clin Endocrinol Metab, 97, 3333, 10.1210/jc.2012-1544 · DOI · Paper page
  9. Han, 2010, Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice, FASEB J, 24, 2869, 10.1096/fj.09-148155 · DOI
  10. Swirski, 2009, Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis, Arterioscler Thromb Vasc Biol, 29, 1424, 10.1161/ATVBAHA.108.180521 · DOI
  11. Bouhlel, 2007, PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties, Cell Metab, 6, 137, 10.1016/j.cmet.2007.06.010 · DOI · Paper page
  12. Kotliar, 2012, Local and systemic cellular immunity in early renal artery atherosclerosis, Clin J Am Soc Nehprol, 7, 224, 10.2215/CJN.06270611 · DOI
  13. Devaraj, 2011, Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications, Metabolism, 60, 256, 10.1016/j.metabol.2010.01.005 · DOI
  14. Anderson, 2010, Adipose tissue recruitment of leukocytes, Curr Opin Lipidol, 21, 172, 10.1097/MOL.0b013e3283393867 · DOI
  15. Swirski, 2007, Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata, J Clin Invest, 117, 195, 10.1172/JCI29950 · DOI · Paper page

Cited by

See all 198

Metadata

Authors
Satoh-Asahara, N., Sasaki, Y., Wada, H., Tochiya, M., Iguchi, A., Nakagawachi, R., Odori, S., Kono, S., Hasegawa, K., & Shimatsu, A.
Venue
Metabolism
Publisher
Elsevier BV
Published
2013-03
Volume
62
Issue
3
Pages
347-351
ISSN
0026-0495 (ISSN-L)
OpenAlex
W2042503458
Cited by
198
References
5
FWCI
10.35
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • Smoking Research Foundation
  • Ministry of Education, Culture, Sports, Science and Technology
  • Ministry of Health, Labour and Welfare

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients. https://app.cochat.ai/papers/10.1016/j.metabol.2012.09.004
The paper
Satoh-Asahara, N., Sasaki, Y., Wada, H., Tochiya, M., Iguchi, A., Nakagawachi, R., Odori, S., Kono, S., Hasegawa, K., & Shimatsu, A. (2013). A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients. Metabolism. https://doi.org/10.1016/j.metabol.2012.09.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.